JAPAN IP CATALYST
Emerging & Hybrid IPAI & Future

Regenerative Medicine (iPS Cells)

Popularity
Overview

Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS cell technology. Since the 2012 Nobel Prize, clinical applications have steadily advanced. Japan leads the world in practical iPS cell treatments for retinal diseases, heart disease, and Parkinson's disease.

Last catalogued:Editor: JAPAN IP CATALYSTEditorial policyReferences: See web links below

Note: This content was generated as an idea by our editorial AI from public sources.

Metadata
Subcategory:AI & Future
Location:Kyoto (Kyoto University)
Time Period:2006-present
Influence:Global
Tags
iPS CellsRegenerative MedicineNobel Prize

Contemporary IPs

1986Dragon Ball (Anime)Content IP
1986The Legend of ZeldaContent IP
1986CastlevaniaContent IP
1986The Legend of ZeldaContent IP
1986Dragon QuestContent IP
1986Dragon QuestContent IP
1986Hideo KojimaContent IP
1986Nobuo UematsuContent IP
1986Maison IkkokuContent IP
1986Honda ASIMO RobotIndustrial & Brand IP
2006Regenerative Medicine (iPS Cells)Emerging & Hybrid IP

Recent News

Loading...

📱 Share on Social

Discovered: Regenerative Medicine (iPS Cells)!

Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS …

#iPSCells #RegenerativeMedicine #NobelPrize
#JAPANIPCATALYST #JapanCulture

Similar IPs